Higher Levels of SDMA and Not ADMA Are Associated With Poorer Survival of Trial Patients With Systemic ANCA-associated Vasculitis
European Journal of Rheumatology
doi 10.5152/eurjrheum.2018.17119
Full Text
Open PDFAbstract
Available in full text
Date
August 27, 2018
Authors
Publisher
AVES Publishing Co.